Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series-Reference-Cited by-同舟云学术

Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series

Published:2014-01-09 Issue:2 Volume:123 Page:177-183
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Rosenberg Joshua D.¹,Burian Carol¹,Waalen Jill²,Saven Alan¹

Affiliation:

1. Division of Hematology/Oncology, Scripps Clinic, La Jolla, CA; and

2. The Scripps Research Institute, La Jolla, CA

Abstract

Key Points HCL patients ≤40 years at diagnosis treated with cladribine obtain complete and durable responses, but ultimately relapse. There was no increased risk of second primary malignancies in young hairy cell leukemia patients followed for protracted periods.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/123/2/177/1376999/177.pdf

Reference20 articles.

1. Leukemic reticuloendotheliosis.;Bouroncle;Blood,1958

2. BRAF mutations in hairy-cell leukemia.;Tiacci;N Engl J Med,2011

3. Alpha interferon for induction of remission in hairy-cell leukemia.;Quesada;N Engl J Med,1984

4. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.;Grever;J Clin Oncol,1995

5. Pentostatin in the treatment of advanced hairy cell leukemia.;Kraut;J Clin Oncol,1989

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the Molecular;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Hairy cell leukemia – etiopathogenesis, diagnosis and modern therapeutic approach;Biochemia medica;2024-06-15

3. Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience;Leukemia Research;2024-05

4. Real‐world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL‐CLLEAR study;Hematological Oncology;2024-05

5. Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical Translation;Current Topics in Medicinal Chemistry;2024-05